George Salti, M.D., Surgical Oncologist & Co-Medical Director, Edward Cancer Center
Dr. Salti completed his undergraduate and medical degrees from the University of Chicago. He then joined the University of Illinois Residency Program in General Surgery where he also completed fellowship training in Surgical Oncology. He currently holds the rank of Associate Professor of Surgery at the University of Illinois at Chicago.
Dr. Salti is interested in the surgical treatment of cancer, including melanoma, sarcoma pancreatic cancer, hepatobiliray cancer, and gastrointestinal and esophageal cancers. Dr. Salti is certified by the American Board of Surgery. He is a fellow of the American College of Surgeons and a member of the American Hepato-Pancreato-Biliary Association, American Society of Breast Surgeons, American Society of Clinical Oncology, American Society of
Peritoneal Surface Malignancy, Society for Melanoma Research, Society of American Gastrointestinal Endoscopic Surgeons, and the Society of Surgical Oncology.
In addition, Dr. Salti has developed a special interest in the surgical management of peritoneal carcinomatosis and is one of only few surgeons who treat peritoneal carcinomatosis with cytoreductive surgery and heated intraperitoneal chemotherapy. This is also known as the HIPEC procedure.
HIPEC stands for heated intraperitoneal chemotherapy. It is used in conjunction with surgery to treat advanced abdominal cancers. Dr. Salti has applied this surgical technique to treat such cancers as pseudomyxoma peritonei, mucinous adenocarcinoma of the appendix, mesothelioma, colorectal carcinoma, sarcoma, stomach cancer, and recurrent ovarian cancer that have spread to the lining surfaces of the peritoneal (abdominal) cavity.
HIPEC is performed during surgery. Once the tumor is removed, a procedure referred to as "cytoreduction", a heated chemotherapy solution is used to bathe the abdominal cavity in an attempt to eradicate tumor cells that may remain after surgery. Both heat and chemotherapy kill cancer cells.
There is now substantial clinical evidence to suggest that HIPEC is the preferred treatment for patients with certain types of cancers.
See his profile in our physician directory or watch his video .